Semaglutide associated with increased walking distance in patients with symptomatic peripheral artery disease and type 2 diabetes.
Danish pharmaceutical company Novo Nordisk is set to launch its anti-diabetes and weight-loss drug Wegovy in India, aiming to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback